Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hassell

Showing results (161-170 of 213) with videos related to

Pageof 22
Sort By:
The Journal of Rheumatology|January 1, 1997
Tumor necrosis factor microsatellite haplotypes are different in male and female patients with RAA Hajeer, S John, W E Ollier, et al.
Archives of Pathology & Laboratory Medicine|June 24, 2025
The Accreditation Journey for a Hospital in the Developing WorldHang Thi Nguyen, Gail H Vance, Lewis A Hassell, et al.
Molecular and Cellular Biology|September 1, 1997
A role for the ETS domain transcription factor PEA3 in myogenic differentiationJ M Taylor, E E Dupont-Versteegden, J D Davies, et al.
BMC Cancer|July 30, 2016
The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signaturesJessica G Cockburn, Robin M Hallett, Amy E Gillgrass, et al.
Biochimica Et Biophysica Acta|October 31, 2015
Methylation-dependent regulation of hypoxia inducible factor-1 alpha gene expression by the transcription factor KaisoChristina C Pierre, Joseph Longo, Blessing I Bassey-Archibong, et al.
Journal of Virology|March 1, 1990
Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma proteinN Dyson, R Bernards, S H Friend, et al.
Oncotarget|April 14, 2017
Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenograftsWilliam D Gwynne, Robin M Hallett, Adele Girgis-Gabardo, et al.
Oncogene|June 14, 2011
Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancerM Kondratyev, A Kreso, R M Hallett, et al.
Journal of Clinical Pharmacology|February 13, 1999
Lack of effect of erythromycin and ketoconazole on the pharmacokinetics and pharmacodynamics of steady-state intranasal levocabastineL Pesco-Koplowitz, A Hassell, P Lee, et al.
Plos One|April 5, 2013
Single unpurified breast tumor-initiating cells from multiple mouse models efficiently elicit tumors in immune-competent hostsNatasza A Kurpios, Adele Girgis-Gabardo, Robin M Hallett, et al.
Pageof 22

Showing results (161-170 of 213) with videos related to

Sort By:
Pageof 22
The Journal of Rheumatology|January 1, 1997
Tumor necrosis factor microsatellite haplotypes are different in male and female patients with RAA Hajeer, S John, W E Ollier, et al.
Archives of Pathology & Laboratory Medicine|June 24, 2025
The Accreditation Journey for a Hospital in the Developing WorldHang Thi Nguyen, Gail H Vance, Lewis A Hassell, et al.
Molecular and Cellular Biology|September 1, 1997
A role for the ETS domain transcription factor PEA3 in myogenic differentiationJ M Taylor, E E Dupont-Versteegden, J D Davies, et al.
BMC Cancer|July 30, 2016
The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signaturesJessica G Cockburn, Robin M Hallett, Amy E Gillgrass, et al.
Biochimica Et Biophysica Acta|October 31, 2015
Methylation-dependent regulation of hypoxia inducible factor-1 alpha gene expression by the transcription factor KaisoChristina C Pierre, Joseph Longo, Blessing I Bassey-Archibong, et al.
Journal of Virology|March 1, 1990
Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma proteinN Dyson, R Bernards, S H Friend, et al.
Oncotarget|April 14, 2017
Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenograftsWilliam D Gwynne, Robin M Hallett, Adele Girgis-Gabardo, et al.
Oncogene|June 14, 2011
Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancerM Kondratyev, A Kreso, R M Hallett, et al.
Journal of Clinical Pharmacology|February 13, 1999
Lack of effect of erythromycin and ketoconazole on the pharmacokinetics and pharmacodynamics of steady-state intranasal levocabastineL Pesco-Koplowitz, A Hassell, P Lee, et al.
Plos One|April 5, 2013
Single unpurified breast tumor-initiating cells from multiple mouse models efficiently elicit tumors in immune-competent hostsNatasza A Kurpios, Adele Girgis-Gabardo, Robin M Hallett, et al.
Pageof 22